Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07624539 · ClinicalTrials.gov registry record · NA
Device for Alleviating Temporomandibular Joint (TMJ) Pain
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT07624539 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 31 participants.
The verdict
NCT07624539, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the safety and effectiveness of the investigational BTL-043 device in alleviating Temporomandibular Joint (TMJ) pain in adults aged 22 years and older. The main questions it aims to answer are: Does the BTL-043 device effectively reduce TMJ pain? Does the treatment improve jaw mobility (mandibular range of motion) and reduce the impact of TMJ disorders on daily activities? Is the treatment comfortable and safe for participants? Participants will: Receive four 20-minute treatments with the BTL-043 laser, spaced 2 to 10 days apart. Attend follow-up clinic visits 1 month and 3 months after their final treatment. Complete questionnaires about their pain levels (Visual Analogue Scale), daily activities (TMD Disability Index), and treatment comfort and satisfaction. Have their jaw mobility (mandibular range of motion) measured
Interventions
- DEVICE Treatment with BTL-043
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-08-21 |
| Est. Completion | 2025-05-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07624539
The ClinicalTrials.gov registry entry for NCT07624539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment with BTL-043 is the first listed.
NCT07624539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07624539 about?
NCT07624539 is a clinical study titled "Device for Alleviating Temporomandibular Joint (TMJ) Pain". The goal of this clinical trial is to evaluate the safety and effectiveness of the investigational BTL-043 device in alleviating Temporomandibular Joint (TMJ) pain in adults aged 22 years and older. The main questions it aims to answer are: Does the BTL-043 device effectively reduce TMJ pain? Does ...
What is the current status of trial NCT07624539?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2024-08-21. Estimated completion is 2025-05-14.
What interventions are being tested in trial NCT07624539?
The interventions under investigation include: Treatment with BTL-043 (DEVICE).
Who is sponsoring clinical trial NCT07624539?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.